BioNxt Solutions Inc
CNSX:BNXT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kinik Co
TWSE:1560
|
TW |
BioNxt Solutions Inc
Total Current Assets
BioNxt Solutions Inc
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioNxt Solutions Inc
CNSX:BNXT
|
Total Current Assets
CA$163.7k
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Total Current Assets
$6.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Total Current Assets
CA$524.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
27%
|
|
|
Cronos Group Inc
TSX:CRON
|
Total Current Assets
$944.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
100%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Total Current Assets
$215.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
63%
|
CAGR 10-Years
101%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Total Current Assets
CA$394.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
BioNxt Solutions Inc
Glance View
BioNxt Solutions, Inc. engages in the production, extraction and sale of medical cannabis. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-08-06. The firm is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The firm has research and development operations in North America and Europe, with an operational focus in Germany. The firm is also focused on regulatory approval and commercialization of medical products for European markets.
See Also
What is BioNxt Solutions Inc's Total Current Assets?
Total Current Assets
163.7k
CAD
Based on the financial report for Dec 31, 2024, BioNxt Solutions Inc's Total Current Assets amounts to 163.7k CAD.
What is BioNxt Solutions Inc's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
-61%
Over the last year, the Total Current Assets growth was -77%. The average annual Total Current Assets growth rates for BioNxt Solutions Inc have been -61% over the past three years .
